Background:
The global pandemic which the world has been facing for the past two years has demonstrated the need to study the effects of this virus on mental health. Various studies showed that COVID-19 could be a threat to people's mental health and physical health, but the findings are still very limited. The purpose of the study was to fill an existing gap in corresponding literature by analysing Post Traumatic stress disorder (PTSD) symptoms, somatic complaints, depression and anxiety in COVID-19 patients and studying their comorbidity to determine the impact of the virus on the patients’ mental well-being.
Methods:
Patients diagnosed with COVID-19 took part in the study one month after their discharge from the hospital, accounting for 10% of all COVID-19 patients across Georgia during the research. PTSD Checklist (PCL-5) was used. Depression, somatic symptoms and anxiety were assessed using the Patient Health Questionnaire (PHQ).
Results:
The results have shown that COVID-19, as a traumatic event, presents an association with PTSD, depression, anxiety, and somatic complaints. A high prevalence of depression (38,6%), anxiety (34,9%), and somatic symptoms (47%) was displayed. The overall indirect effect of PTSD on somatic symptoms was significant through depression and anxiety: 0.16, 95% CI [0.08, 0.26]. According to the report, the indirect effect of PTSD on somatic symptoms of depression was 0.12, 95% CI [0.05, 0.20].
Conclusion:
The study presents important findings on the relations between COVID-19 and mental health. Somatic complaints, depression, anxiety and PTSD symptoms were prevalent in participants after a month since they had COVID-19. Correlations between somatic complaints, anxiety, depression and PTSD were also demonstrated. Even with various limitations to this study, it shows how COVID-19 could affect mental health and prepares the groundwork for further, more detailed research, which is necessary.
